欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0481/001
药品名称Fosrenol
活性成分
    • lanthanum(III)carbonate 250.0 mg
剂型Chewable tablet
上市许可持有人Takeda Pharmaceuticals International AG Ireland Branch
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Fosrenol 250 mg Kautabletten
    • France (FR)
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Estonia (EE)
      FOSRENOL
    • Hungary (HU)
      FOSRENOL 250 mg rágótabletta
    • Slovakia (SK)
      Fosrenol 250 mg žuvacie tablety
    • Bulgaria (BG)
      Foster
    • Slovenia (SI)
    • Malta (MT)
    • Lithuania (LT)
      FOSRENOL 250 mg kramtomosios tabletės
    • Latvia (LV)
许可日期2005/03/01
最近更新日期2024/12/12
药物ATC编码
    • V03AE03 lanthanum carbonate
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier [Article 8.3(i)]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase